Data / Medical devices / United States / Instylla, Inc.
Instylla, Inc.: FDA-registered device maker in Bedford, MA, United States, 5 510(k) clearances and 1 PMA approval
Instylla, Inc. is registered with the FDA (registration 3017208642) in Bedford, MA, United States. It lists 3 device types. The FDA files 5 510(k) clearances and 1 PMA approval under its listings, the newest dated December 22, 2025. Registered through 2026. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 3017208642
- Address
- 201 Burlington Rd, North Building, Bedford, MA, United States, 01730
- Owner or operator
- Instylla, Inc. (10077890)
- Roles
- Manufacturer
- First device listed
- October 5, 2020
- Registered through
- 2026
- Brand names listed
- Embrace Hydrogel Embolic System, Instylla Delivery Kit, Instylla Delivery Kit 1mL:1mL, Instylla Microcatheter, Instylla Microcatheter 1.2F
Devices it lists
| Device | Product code | Class | Role | Source |
|---|---|---|---|---|
| Catheter, Continuous Flush | KRA | 2 | Manufacturer | accessdata.fda.gov |
| Embolization Agent, Vascular | QVG | 3 | Manufacturer | accessdata.fda.gov |
| Syringe, Piston | FMF | 2 | Manufacturer | accessdata.fda.gov |
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| December 22, 2025 | K253769 | Instylla Delivery Kit | FMF | Substantially Equivalent | Instylla, Inc. | accessdata.fda.gov |
| February 10, 2022 | K213632 | Instylla Delivery Kit | FMF | Substantially Equivalent | Instylla, Inc. | accessdata.fda.gov |
| April 15, 2021 | K210808 | Instylla Microcatheter 1.2 | KRA | Substantially Equivalent | Instylla, Inc. | accessdata.fda.gov |
| April 21, 2020 | K200744 | Instylla Microcatheter | KRA | Substantially Equivalent | Instylla, Inc. | accessdata.fda.gov |
| October 10, 2019 | K191659 | Instylla Delivery Kit | FMF | Substantially Equivalent | Instylla, Inc. | accessdata.fda.gov |
PMA approvals
Premarket approvals this establishment lists, with the supplements the FDA has decided since.
| Approved | PMA number | Device | Product code | Supplements | Latest decision | Source |
|---|---|---|---|---|---|---|
| August 5, 2025 | P250003 | Embrace(TM) Hydrogel Embolic System | QVG | 10 | October 23, 2026 | accessdata.fda.gov |
Compare with other makers
- All makers of Catheter, Continuous Flush
- All makers of Syringe, Piston
- All makers of Embolization Agent, Vascular
Updated October 23, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.